A new research study aims to stop the progression of early active stage multiple sclerosis in its tracks. There are currently more than 2.5 million people worldwide with MS, a chronic disease that affects the central nervous system.
A new research study aims to stop the progression of early active stage multiple sclerosis in its tracks. There are currently more than 2.5 million people worldwide with MS, a chronic disease that affects the central nervous system.